We are live on
!
Find out more
DMTX
Dimension Therapeutics, Inc
DMTX
DMTX
Delisted
DMTX was delisted on the 6th of November, 2017.
47 hedge funds and large institutions have $32.7M invested in Dimension Therapeutics, Inc in 2017 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 18 increasing their positions, 13 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
38% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 13
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
15% less funds holding
Funds holding: 55 → 47 (-8)
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
64% less capital invested
Capital invested by funds: $90M → $32.7M (-$57.4M)
Holders
47
Holders Change
-8
Holders Change %
-14.55%
% of All Funds
1.17%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
18
Reduced
13
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BlackRock
New York
|
+$1.45M |
| 2 |
TSS
Two Sigma Securities
New York
|
+$164K |
| 3 |
ARTA
A.R.T. Advisors
New York
|
+$101K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$72.1K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$68.1K |
